Clinical Trial Update: Use Lay Language. HA Score to Identify Myeloma Patients Who Could Benefit From HDACi Treatment

View source ↗

Summary

The update describes a method using an HA Score to identify patients with recurrent or refractory multiple myeloma who may benefit from histone deacetylase inhi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Patients With Recurrent or Refractory Multiple Myeloma | Status: UNKNOWN